News Releases

December 9, 2014

Dr. Kenneth Rothman, Distinguished Fellow and Vice President of Epidemiology Research, had the honor of giving the 160th Cutter Lecture on Preventive Medicine at the Harvard School of Public Health on December 3rd, 2014.

...

December 9, 2014

RESEARCH TRIANGLE PARK, N.C. – A new report by researchers at RTI Health Solutions (RTI-HS) and parent company RTI International, found that although healthcare databases have allowed for greater access to real world medical data, using databases to evaluate the safety of medical products is...

December 3, 2014

Over 45 of our scientists and consultants attended the 17th Annual ISPOR European Congress in Amsterdam; below are some of their insights from the conference.

November 14, 2014

RESEARCH TRIANGLE PARK, NC — James (Jamie) Rosenzweig, MD, has joined RTI Health Solutions (RTI-HS), a business unit of RTI International, as senior director of clinical consulting.

October 29, 2014

AMSTERDAM— Researchers from RTI Health Solutions (RTI-HS), a business unit of RTI International, will discuss challenges and solutions for improving European health care at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress in Amsterdam,...

October 17, 2014

Together with colleagues from the University of Glasgow and Biogen Idec, Sorrel Wolowacz, Head of European Health Economics, and Lynda Doward, European Head of Patient-Reported Outcomes, co-authored an...

October 15, 2014

In late September, 2014, the FDA convened a public meeting entitled “Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease and other Heritable Bleeding Disorders." Dr.

August 1, 2014

On July 16, 2014, the Engelberg Center for Health Care Reform, in cooperation with the FDA, held an expert workshop that focused on the major issues related to the development and use of Patient-Reported Outcome (PRO) instruments to support...

July 31, 2014

When you choose a pharmaceutical research partner, you want to know the credentials of the team conducting your research and the relevant experience they bring to your project.

July 17, 2014

We are delighted to announce the seven year anniversary of opening our Barcelona, Spain office.  In the summer of 2007, the office was opened with a small, 5-person research team to strengthen our expert base and research network in Europe to meet the growing pharmacoepidemiological activities...

June 30, 2014

Josephine Mauskopf, Ph.D., vice president of Health Economics at RTI Health Solutions, a business unit of RTI International, has been elected to the board of directors of the International Society for Pharmacoeconomics and Outcomes Research. She will serve a two-year term.

June 23, 2014

A new book, with chapters authored by three researchers at RTI Health Solutions, a business unit of RTI International, provides a first-of-its-kind overview of benefit-risk assessment from both the scientific and...

June 16, 2014

RTI-HS staff led and presented 27 posters, several workshops, a sponsored educational symposium, and other sessions at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting in Montreal, Quebec, Canada, May 31-June 4, 2014. To access our full list of posters and...

May 20, 2014

A new book provides a definitive drug safety resource for pharmaceutical researchers and students. The book brings together 136 experts from around the world who represent all aspects of pharmacovigilance.

March 24, 2014

As long as statins, a class of cholesterol-lowering drugs, remain inexpensive and don’t affect the patient’s quality of life, it is better to simply prescribe the drugs before ordering a heart scan, finds a new study by researchers at University of California at San Francisco; RTI Health...

December 17, 2013

The Scottish Medicines Consortium (SMC) has recommended eltrombopag, for the treatment of thrombocytopenia in patients with hepatitis C virus. See Scottishmedicines.org.uk for additional details.

November 14, 2013

Susana Perez-Gutthann, global head of epidemiology at RTI Health Solutions, has been re-elected by her peers as one of the six research center members of the steering committee of the European...

November 12, 2013

Susana Perez-Gutthann, Vice President, and Global Head of Epidemiology will participate in a webinar entitled Practical Aspects and Examples of Using Large Datasets for Investigating Product Safety and Effectiveness in the US and EU for the DIA Global Forum for Therapeutic Innovation...

September 12, 2013

Researchers from RTI Health Solutions' (RTI-HS) Health Preference Assessment group will speak at an FDA-sponsored public workshop titled "...

July 11, 2013

Elizabeth Andrews, vice president of Pharmacoepidemiology and Risk Management, has been appointed to serve as the Academia/Research Institute representative on the Reagan-Udall...

May 22, 2013

Josephine Mauskopf, Ph.D., vice president of Health Economics at RTI Health Solutions, a business unit of RTI International, received the 2013 Avedis Donabedian Outcomes Research Lifetime Achievement Award...

April 15, 2013

A three-year European project SAFEGUARD, funded by the European Commission, aims to assess and further quantify and understand the effects of all existing blood glucose lowering agents in humans by means of the analysis of anonymised and aggregated data from more than 1.7 million diabetes...

March 7, 2013

Renowned pharmacoepidemiologist Ken Rothman, Distinguished Fellow, Vice President of Epidemiology Research, will join over 20 other leading experts to discuss applications of epidemiologic methods to social and health research.

Pages